Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,298 | -70,513 | -44,989 | -24,061 | -111,566 |
| Depreciation Amortization | 1,245 | 941 | 647 | 325 | 1,371 |
| Accounts payable and accrued liabilities | -2,920 | -1,416 | 2,365 | 3,980 | -2,295 |
| Other Working Capital | -12,467 | -9,866 | -3,984 | 298 | -18,012 |
| Other Operating Activity | 22,215 | 17,937 | 4,659 | -340 | 57,484 |
| Operating Cash Flow | $-81,225 | $-62,917 | $-41,302 | $-19,798 | $-73,018 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -374 | -376 | -341 | -140 | -3,869 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -3,500 |
| Other Investing Activity | 11 | 0 | 0 | 0 | -3,483 |
| Investing Cash Flow | $-363 | $-376 | $-341 | $-140 | $-7,352 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 39,550 |
| Debt Repayment | N/A | N/A | N/A | N/A | -43,000 |
| Common Stock Issued | 76,869 | 77,269 | 70,507 | 26 | 140,858 |
| Other Financing Activity | -185 | -228 | -61 | -48 | -1,015 |
| Financing Cash Flow | $76,684 | $77,041 | $70,446 | $-22 | $136,393 |
| Beginning Cash Position | 146,540 | 146,540 | 146,540 | 146,540 | 90,517 |
| End Cash Position | 141,636 | 160,288 | 175,343 | 126,580 | 146,540 |
| Net Cash Flow | $-4,904 | $13,748 | $28,803 | $-19,960 | $56,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,225 | -62,917 | -41,302 | -19,798 | -73,018 |
| Capital Expenditure | -374 | -376 | -341 | -140 | -3,869 |
| Free Cash Flow | -81,599 | -63,293 | -41,643 | -19,938 | -76,887 |